It is postulated that inadequate remodeling of the uterine spiral arteries in preeclampsia leads to focal ischemia and generation of inflammatory cytokines, such as tumor necrosis factor (TNF␣) and interleukins (ILs), by the placenta. Our objective was to compare TNF␣, IL-1␣, IL-1␤, and IL-6 levels in placentas from patients with preeclampsia and normal term pregnancies. Because the placenta is a large heterogeneous organ, we analyzed multiple sites per placenta. On the average, there was a 3-fold variation in cytokine protein levels across the eight sites analyzed for each placenta. However, there were no significant overall differences among the normal term, preeclamptic, and preterm placentas from women without preeclampsia. There were also no significant differences in TNF␣ messenger ribonucleic acid between the normal term and preeclamptic placentas, although TNF␣ messenger ribonucleic acid levels were lower in placentas from preterm patients without diagnosis of preeclampsia than in the normal term placentas. In vitro, hypoxia stimulated the production of TNF␣, IL-1␣ and IL-1␤, but not that of IL-6, by placental villous explants from both groups of patients, and this was not exaggerated in preeclampsia. Finally, although peripheral and uterine venous levels of TNF␣ were elevated in preeclamptic women compared with normal term patients, the ratio of uterine to peripheral venous TNF␣ levels was not significantly different from 1.0 for either patient group. Taken together, these results suggest that sources other than the placenta contribute to the elevated concentrations of TNF␣ and IL-6 found in the circulation of preeclamptic women. . 2), and the etiology of preeclampsia relates to deficient physiological remodeling of uterine spiral arteries (3). Without sufficient changes in the uterine vasculature in early pregnancy, the placenta is susceptible to the development of focal regions of ischemia/hypoxia. In turn, reduced oxygen tension in the placental tissue may lead to the production and secretion of cytotoxic factors that have been postulated to affect the maternal vasculature (4). Inflammatory cytokines such as tumor necrosis factor-␣ (TNF␣) and interleukin-1␤ (IL-1␤) can produce endothelial dysfunction (5), and synthesis of these cytokines as well as IL-6 has been documented in the human placenta (6 -9). Further, we have shown that incubation of human placental explants under reduced oxygen conditions results in the elevated production of TNF␣, IL-1␣, and IL-1␤ (9).
TNF␣ messenger ribonucleic acid levels were lower in placentas from preterm patients without diagnosis of preeclampsia than in the normal term placentas. In vitro, hypoxia stimulated the production of TNF␣, IL-1␣ and IL-1␤, but not that of IL-6, by placental villous explants from both groups of patients, and this was not exaggerated in preeclampsia. Finally, although peripheral and uterine venous levels of TNF␣ were elevated in preeclamptic women compared with normal term patients, the ratio of uterine to peripheral venous TNF␣ levels was not significantly different from 1.0 for either patient group. Taken together, these results suggest that sources other than the placenta contribute to the elevated concentrations of TNF␣ and IL-6 found in the circulation of preeclamptic women. (J Clin Endocrinol Metab 86: 2505-2512, 2001) P REECLAMPSIA IS A disease of human pregnancy diagnosed by the onset of hypertension and proteinuria in the third trimester (1) . Several investigators have suggested that endothelial dysfunction underlies the disease manifestations (reviewed in Ref. 2) , and the etiology of preeclampsia relates to deficient physiological remodeling of uterine spiral arteries (3) . Without sufficient changes in the uterine vasculature in early pregnancy, the placenta is susceptible to the development of focal regions of ischemia/hypoxia. In turn, reduced oxygen tension in the placental tissue may lead to the production and secretion of cytotoxic factors that have been postulated to affect the maternal vasculature (4) . Inflammatory cytokines such as tumor necrosis factor-␣ (TNF␣) and interleukin-1␤ (IL-1␤) can produce endothelial dysfunction (5) , and synthesis of these cytokines as well as IL-6 has been documented in the human placenta (6 -9) . Further, we have shown that incubation of human placental explants under reduced oxygen conditions results in the elevated production of TNF␣, IL-1␣, and IL-1␤ (9) .
We and others (reviewed in Refs. 10 and 11) reported that circulating levels of TNF␣ and IL-6 are increased in women with preeclampsia. Given that the placenta produces inflammatory cytokines, some of which can be stimulated by hypoxia in vitro, our objective was to determine whether placental protein and messenger ribonucleic acid (mRNA) levels for TNF␣, IL-1␣, IL-1␤, and IL-6 are elevated in women with preeclampsia. Further, placental tissues from normal pregnant and preeclamptic women were incubated in 21% or 2% oxygen to determine whether there are differences in the magnitude of hypoxia-stimulated cytokine production. A final objective was to compare peripheral circulating levels of TNF␣ with those in the uterine vein to directly ascertain whether the uteroplacental unit contributes to the systemic elevation of inflammatory cytokines in women with preeclampsia.
Subjects and Methods

Human subjects
All placentas were obtained from women undergoing cesarian section without labor under approval of the institutional review board at Magee-Womens Hospital. Placentas from nulliparous patients with normal pregnancies were collected at term (38 -41 gestational weeks). Placentas were obtained from nulliparous women with preeclampsia at 28 -38 gestational weeks. The diagnosis of preeclampsia was made by strict criteria: onset of hypertension during the third trimester (Ն140/90 mm Hg on two occasions), detectable urinary protein (Ն1ϩ by dipstick or Ն300 mg/24 h), and plasma uric acid levels exceeding 1 sd from the mean for gestational age (in five of six patients). For placental samples used for cytokine protein and mRNA analyses, two preeclamptic patients of less than 35 weeks gestation received ␤-methasone, one of whom also had a diagnosis of HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets), and two of the preeclamptic patients had growth-restricted infants. For placental samples used in explant culture, three of the six patients were less than 30 gestational weeks and received ␤-methasone, and two had growth-restricted infants.
As an additional control group, six placentas were obtained from nulliparous women with preterm delivery and without preeclampsia (28 -32 gestational weeks). These patients with preterm deliveries were also delivered by cesarian section (one with labor), and all neonates were of appropriate size for gestational age. Only one patient had chorioamnionitis, which was reported as mild by the perinatal pathologist.
Patients from whom uterine and peripheral venous blood samples were taken at cesarean delivery were selected in Oxford, using different criteria. All gave their written and informed consent to take part in the study, which was approved by the Central Oxford research ethics committee. Women with preeclampsia (n ϭ 8) had clear documentation of no proteinuria earlier in pregnancy after which at least 2ϩ protein, as a new development, was detected using dipstick testing. Their diastolic pressures had increased from less than 90 mm Hg before 20 weeks gestational age to more than 90 mm Hg before delivery, recorded on at least two occasions. There was no restriction with regard to parity, and plasma uric acid measurements were not used as selection criteria. Normal pregnant women (n ϭ 8) required cesarean delivery for nonurgent reasons, such as breech presentation or elective repeat cesarean delivery. They never had proteinuria, and at no time during their uncomplicated pregnancies were diastolic pressures of 90 mm Hg or more recorded. None was taking regular medications for any purpose. The cases and controls were not matched in any respect, except for delivery by cesarean section.
Collection of placental samples
Immediately after delivery of the placenta by cesarian section, samples were collected, and the total length of processing time was less than 15 min. As the placenta is a large heterogeneous organ, and sampling bias is a potential hazard (12), a square grid of 16 holes in a 4 ϫ 4 design within a circular template was constructed to overlay the placenta. Templates of various sizes were prepared to best fit placentas of different diameters. After blotting the maternal surface of blood, a sterile nickel cork borer was inserted into each of the 16 holes (ϳ1 cm) to obtain a full thickness biopsy (ϳ0.5 g tissue, which excluded the chorionic plate). Each sample was briefly rinsed 3 times in cold saline, blotted dry, and flash-frozen in individual bags in liquid nitrogen.
Preparation of placental homogenates
The frozen placental sample was pulverized on dry ice, and approximately 100 mg were transferred to 5-mL polypropylene tubes. Each tube had a cocktail of protease inhibitors added (phenylmethylsulfonylfluoride, leupeptin, antipain, pepstatin A, and soybean trypsin inhibitor; Sigma, St. Louis, MO). Placental samples were then homogenized with a Tissumizer (Tekmar, Cincinnati, OH) for 30 s on ice in a 2-fold volume of homogenizing buffer [50 mmol/L Tris (pH 7.4) and 1 mmol/L ethylenediamine tetraacetate; Fisher Scientific, Pittsburgh, PA]. The homogenate was centrifuged at 3,000 ϫ g for 10 min at 4 C, and then the collected supernatant was centrifuged at 10,000 ϫ g for 15 min at 4 C. Two 10-L aliquots were analyzed for protein concentration by the Lowry method, and the remaining sample was aliquoted and stored at Ϫ80 C until enzyme-linked immunosorbent assay (ELISA) analysis.
For ELISA analysis, samples were used from odd-numbered sites, and thus eight samples per placenta were analyzed. Samples were run in duplicate on two separate ELISA plates, and the normal and preeclamptic samples were pipetted into alternating wells. To control for any gestational age effect, homogenates were prepared from a single placental biopsy site from preterm deliveries without preeclampsia (only one sample was available from these patients). In this final study normal term and preeclamptic placental homogenates were prepared as a pool of four sites per placenta and assayed for TNF␣ and IL-6 levels in duplicate. Placental homogenates were diluted in the manufacturer's serum diluent to fall within the linear portion of the respective standard curves as determined in preliminary studies. Results were then normalized per mg protein.
ELISA of placental homogenates
All ELISAs were performed using kits obtained from R&D Systems, Inc. (Minneapolis, MN). For TNF␣, IL-1␤, and IL-6, Quantikine HighSensitivity kits were used, with sensitivities of 0.5, 0.125, and 0.156 pg/mL, respectively, whereas the sensitivity for the IL-1␣ assay was 3.9 pg/mL. A limited number of samples were also evaluated for IL-12 by an ELISA that had a sensitivity of 0.781 pg/mL. All assays were conducted according to manufacturer's protocols.
The cytokine ELISAs of placental homogenates were extensively validated for dilutional parallelism and monitored for recovery of recombinant human cytokine standards in homogenates to assure no interference by substances in the crude samples. Linearity was assessed for TNF␣, IL-1␤, and IL-6 in placental samples (prepared as a pool of homogenates from three each normal and preeclamptic samples), which were assayed in three dilutions. These experiments were performed in duplicate, and the data are expressed as a percentage of the measured values (observed) divided by the calculated value from assay of the initial pooled sample (expected), as shown in Table 1 . Dilutional analysis was not performed for IL-1␣ and IL-12, because the samples were undetectable at dilutions greater than 1:2. Recovery of samples spiked with the respective recombinant human cytokine standard was performed with three concentrations of the standard added to diluted, pooled samples (n ϭ 3 each for normal and preeclamptic placental homogenates).
Semiquantitative RT-PCR
For determination of TNF␣ and ␤-actin mRNA expression in the preeclamptic and normal term placentas, total RNA was pooled from four biopsy sites per placenta, and six placentas in each group were analyzed. Only one biopsy site was available for the six placentas from preterm deliveries without preeclampsia. Total RNA was isolated from placental tissues using RNAwiz (Ambion, Inc., Austin, TX). RNA from the four biopsy sites per placenta were then combined, and contaminating genomic DNA was removed using DNA-free (Ambion, Inc.). The concentration of pooled RNA was measured by spectrophotometry. Before performing RT-PCR, we verified that each pool of RNA was of high quality by ethidium bromide staining of total RNA (2.5 g) separated on a formaldehyde-containing 1.5% agarose gel, and well defined bands were observed for both 18S and 28S RNA with no visible degradation (data not shown).
Human TNF␣ and ␤-actin primers were purchased from R&D Systems, Inc. (Minneapolis, MN), or manufactured by the DNA Synthesis Facility at the University of Pittsburgh. For TNF␣, the forward and reverse sequences were GTGACAAGCCTGTAGCCCA and ACTCG-GCAAAGTCGAGATAG, respectively. Using these primers, the RT-PCR fragment was 414 bp, whereas amplification of genomic DNA would have yielded a 714-bp fragment. For ␤-actin, the forward and reverse sequences were CTACAATGAGCTGCGTGTGG and AAG-GAAGGCTGGAAGAGTGC, respectively. Using these primers, the RT-PCR fragment was 528 bp, whereas amplification of genomic DNA would have yielded a 969-bp fragment. Observed/expected ϫ 100%, average of duplicate assays. a Dilution at which all samples were used in subsequent assays. Dilutional analyses were not performed for IL-1␣ and IL-12 because these samples could only be diluted 1:2 due to low assay sensitivity.
The semiquantitative RT-PCR technique was modified based on that previously described (13) , and all reactions were prepared in an Airclean 600 Workstation with a UV light to prevent contamination (Airclean Systems, Raleigh, NC). Total RNA (5 g) was annealed with 30 ng of each of the reverse primers in a total volume of 10.5 L. Using a Genius thermocycler (Techne, Princeton, NJ), the mixture was incubated for 10 min at 75 C, cooled to 42 C at 0.2 C/min, maintained at 42 C for 15 min, and then held at 4 C until further processing. Next, an RT master mix was prepared, and 9.5 L were added to each annealing reaction con-
The mixture was incubated for 45 min at 42 C, heated to 95 C for 5 min, and then held at 4 C until further processing. Separate PCR master mixes were then prepared containing either the TNF␣ or ␤-actin primer pairs (kept on ice). One L of the RT reaction was added to 19 L of the ␤-actin PCR master mix, and 2 L of the RT reaction was added to 18 L of the TNF␣ master mix. Preliminary experiments were conducted to determine the optimal amount of dNTP and MgCl 2 in these master mixes. For ␤-actin, the PCR master mix consisted of 1 L buffer (20ϫ stock), 1.
, and 4 L of the TNF␣ primer pair (2 mol/L). The mixtures were titurated and placed in the thermal cycler at 4 C. Then the lid was heated at 94 C for 2 min, followed by heating of the reactions at 94 C for 5 min. Each cycle consisted of 1 min each at 94, 55, and 72 C. After completion of the PCR, the reactions were maintained at 4 C until further processing. To determine the optimal number of PCR cycles for ␤-actin and TNF␣, we tested 15-33 cycles in intervals of 3 for ␤-actin and 24 -42 cycles for TNF␣ and used 21 and 31 cycles, respectively, for subsequent analyses (Fig. 1) . Further, we determined a linear relationship between the input of complementary DNA (cDNA) and the amount of PCR products generated with cDNA equivalent to 2.5, 1.25, and 0.625 g total RNA (data not shown).
All PCR products were subjected to Southern blotting. cDNA probes were made using 25-50 ng TNF␣ (ATCC 39894, American Type Culture Collection, Manassas, VA; PstI fragment of 1.1 kb) or ␤-actin (ATCC 65128, EcoRI fragment of 1.1 kb) insert, 50 Ci [ 32 P]dCTP (3000 Ci/mol; NEN Life Science Products-DuPont, Boston, MA), and 2 U Klenow polymerase using the Multiprime DNA labeling kit (Amersham Pharmacia Biotech, Piscataway, NJ). Unincorporated 32 P was removed using a spin column (Biospin P30, Bio-Rad Laboratories, Inc., Hercules, CA). After decanting the prehybridization solution, labeled probe and 6 mL High Efficiency Hybridization System with 50% formamide (MRC, Cincinnati, OH) were added, and hybridization was performed overnight at 42 C. For posthybridization, the Washing/Prehyb solution was again used at room temperature and at 50 C as needed. The membranes were exposed to Kodak BioMax MR film (Eastman Kodak Co., Rochester, NY) for 10 -20 min. The authenticity of the RT-PCR fragment for TNF␣ was verified by restriction enzyme digestion for total RNA from the placental pool and from human monocytic HL-60 cells stimulated with lipopolysaccharide.
Villous explant culture
Villous explant cultures were prepared as previously described (9) . Briefly, blunt dissection of placental cotyledons (3-5/placenta) was performed to remove decidual tissue and large blood vessels. This was followed by fine dissection of 5-to 10-mg pieces of villous placenta bathed in 0.9% saline, which were placed into 24-well plates (35-50 mg total tissue) containing 1 mL medium 199 (Mediatech, Herndon, VA) with 10% FCS (Summit Technology, Ft. Collins, CO) and penicillinstreptomycin-gentamicin. Explants were incubated at 37 C with either no preincubation period or a 24-h preincubation. Incubations were carried out on an orbital shaker (60 rpm) under either standard tissue culture conditions of 5% CO 2 -95% room air or hypoxia (2.1% O 2 -5% CO 2 -balance N 2 ). At the end of the experiment, tissue weight was recorded so that cytokine values could be corrected per wet weight, and the conditioned medium was stored at Ϫ80 C. The viability of villous explants was monitored at experiment termination by assessment of lactate dehydrogenase release into spent medium as previously described (9).
Peripheral and uterine venous blood samples
TNF␣ was measured in plasma or serum using an ELISA kit obtained from R&D Systems, Inc., as previously described (11) . Blood was taken from a superficial vein on the lower lateral uterine segment. If the placenta was lateralized (as predicted by ultrasonography), the placental side was chosen. The vein was cannulated by a 21-gauge butterfly needle, and up to 20 mL were drawn into standard blood collection vials (Becton Dickinson and Co., Mountain View, CA). Less than 10 min earlier an equivalent blood sample was drawn from a peripheral arm or foot vein and processed in an identical manner. As soon as the samples without anticoagulant had clotted, they were centrifuged at 2500 ϫ g, and the serum or plasma was separated and stored at Ϫ80 C. The samples were transported to Pittsburgh, unthawed, on dry ice for assay.
Data analysis
Cytokine protein levels in the multiple samples of normal and preeclamptic placental homogenates were analyzed by two-factor repeated measures ANOVA. For comparison of placental TNF␣/␤-actin mRNA expression in preeclamptic, preterm (without preeclampsia), and term samples, we employed a one-factor randomized block design ANOVA. Differences in cytokine production by villous explants from normal and preeclamptic placentas cultured under standard tissue culture conditions or hypoxia were compared by two-factor randomized block design ANOVA. Fisher's least significant difference test was used for post-hoc comparisons of individual means. Finally, an unpaired t test and onesample sign test, respectively, were used to compare TNF␣ in blood samples from preeeclamptic and normal term women and to determine whether the ratio of TNF␣ in the uterine and peripheral venous blood was different from unity. P Ͻ 0.05 was taken as significant.
Results
Placental cytokine protein and mRNA
To test whether the use of crude placental homogenates in cytokine ELISAs would introduce cross-reacting or interfering substances, all assays were validated by dilutional parallelism (Table 1 ) and recovery of spiked recombinant human cytokine standards. All cytokine levels were detectable within a linear portion of the standard curves with appropriate sample dilution. The overall recovery of cytokine standards spiked into pooled placental homogenates ranged from 90 -107% for the TNF␣, IL-1␣, IL-1␤, IL-6, and IL-12 assays. Table 2 depicts cytokine protein levels in placental homogenates from normal term and preeclamptic placentas after multiple site biopsy. Each of eight biopsies per placenta was analyzed by specific assay, and then the values obtained for the eight sites were averaged for each placenta. There were no significant differences in levels of TNF␣, IL-1␤, IL-1␣, or IL-6 in the placentas from normal term compared with preeclamptic pregnancies. In addition, in a limited number of samples (three sites per placenta, four patients), IL-12 levels did not differ (term, 4.3 Ϯ 1.0 pg/g; preeclamptic, 4.1 Ϯ 1.0 pg/g; mean Ϯ sem). Within each placenta, there was a 3-fold range in cytokine values obtained over the eight sites assayed (Fig. 2) . This variation within a placenta was similar between patient groups and was not related to the anatomical location of the biopsy.
To control for differences in gestational age between the normal term (ϳ39 weeks) and preeclamptic patients (ϳ33.5 weeks), single site biopsies were obtained from a group of preterm patients without preeclampsia, and placental homogenates were assayed for TNF␣ and IL-6 levels. Again, there were no significant differences in placental TNF␣ and IL-6 concentrations (Table 3) . Figure 3 shows the confirmation of TNF␣ mRNA expression in the human placenta by restriction enzyme digestion using HincII. Two fragments of 169 and 245 bp were predicted. This pattern was observed for RT-PCR products in the total RNA pooled from three normal term placentas and in lipopolysaccharide-stimulated HL-60 cells that served as a positive control for TNF␣ production. Figure 4 portrays the results for TNF␣ and ␤-actin mRNA expression for the normal term and preeclamptic placentas. There were no significant differences between the two groups of placentas. In contrast, normalized TNF␣ expression was significantly lower in the preterm placentas without preeclampsia than in the normal term placenta (P Ͻ 0.05; Fig. 5 ).
Villous placental tissues from normal term and preeclamptic patients were also maintained in explant culture under Values are the mean Ϯ SEM, average of eight sites assayed in duplicate per placenta for normal term (n ϭ 5) and preeclamptic (n ϭ 4) patients. There are no significant differences between groups. Values are the mean Ϯ SEM. Four biopsy sites were combined for normal term (n ϭ 6) and preeclamptic (n ϭ 4) samples, and a single site from preterm (n ϭ 6) placentas was analyzed. There are no significant differences among groups.
FIG. 2.
Variation in TNF␣ protein levels in eight-site biopsies of normal term and preeclamptic placentas. E, TNF␣ levels at eight individual sites from normal term and preeclamptic placentas (samples analyzed in duplicate by ELISA).
various conditions to determine whether cytokine production differed in response to oxygen. Cytokine concentrations were first measured in medium after maintaining villous explants (n ϭ 5/group) for 24 h under standard tissue culture conditions. There were no initial differences in TNF␣ production between term and preeclamptic placental villous explants (91 Ϯ 12 vs. 97 Ϯ 32 pg/g wt) or in IL-1␤ (173 Ϯ 78 vs. 107 Ϯ 27 pg/g wt). After this 24-h incubation, villous explants were placed into fresh medium and incubated for an additional 24 h under standard tissue culture conditions (21% oxygen) or under 2.1% O 2 (hypoxia). As presented in Fig. 6 , exposure to reduced oxygen significantly stimulated the production of TNF␣, IL-1␤, and IL-1␣ in villous explants obtained from both normal term and preeclamptic placentas. Hypoxia did not affect IL-6 production by villous explants.
IL-6 and TNF␣ levels were significantly reduced, however, in villous explants prepared from preeclamptic vs. normal term placenta. Finally, in two placentas from each patient group, decidual basal plate was incubated in a similar fashion; however, no differences in TNF␣ or IL-6 levels were observed (data not shown).
Last, blood samples were obtained at cesarian section from women with and without preeclampsia. These serum samples were collected from a vein in the antecubital fossa and from the uterine vein. There was an elevation in circulating TNF␣ levels in the preeclamptic women, and this difference was maintained across uterine circulation (Table 4) . To determine whether this elevation in peripheral levels was of uteroplacental origin, uterine venous levels were taken as a ratio of peripheral venous levels. This ratio did not differ significantly from 1.0 in either patient group (term, 1.04 Ϯ 0.05; preeclamptic, 0.98 Ϯ 0.03).
Discussion
The failure of the uterine vasculature to undergo adequate physiological remodeling in women with preeclampsia has led a number of investigators to postulate that a consequence of reduced placental perfusion is the generation of cytotoxic factors that circulate and injure the maternal endothelium (1-4) . Indeed, we previously reported that the normal human placenta can produce more inflammatory cytokines, including TNF␣, when incubated under low oxygen tension (9) . Inflammatory cytokines are notorious for affecting the endothelium in a fashion similar to events reported in preeclamptic women (2, 5) , and TNF␣ levels are higher in the circulation of women with preeclampsia (11) . Therefore, in the present work we investigated whether the placenta is the source of increased circulating TNF␣ and IL-6 in preeclampsia. Placental concentrations of other inflammatory cytokines, such as IL-1␣, IL-1␤, and IL-12, were also evaluated.
As the placenta is a large heterogeneous organ, we sampled each placenta in a systematic and unbiased fashion (12) . We constructed circular grids, each with 16 holes to fit over a placenta for multiple sampling. This allowed us to obtain punch biopsies without bias toward the condition of the placenta (although if sections were taken near areas of gross infarctions, this was noted), and sample collection was completed within 15 min of delivery. Also, in these studies only placentas obtained after cesarian section in women without labor were used, because others have reported elevated levels of TNF␣ and IL-6 in amniotic fluid with labor (14) .
Inflammatory cytokines were readily detected in homogenates prepared from all biopsies in the normal term and preterm placentas (with and without preeclampsia). Comparison of cytokine protein levels within a single placenta demonstrated a 3-fold variation among sites that was independent of anatomic location or patient group. In retrospect, our strategy of obtaining multiple biopsies in a systematic and unbiased fashion (as opposed to single sampling) was warranted in view of this highly variable expression. In contrast to a previous report (15), we did not find an elevation in TNF␣ protein levels in the preeclamptic placenta, nor did we detect increased TNF␣ protein levels in the conditioned media of villous explants from preeclamptic placentas; in fact, significantly lower levels were detected in media from samples incubated under standard tissue culture conditions. Further, our evaluation of TNF␣ mRNA using semiquantitative RT-PCR did not demonstrate any significant differences in TNF␣ mRNA between normal term and preeclamptic placentas, although differences have been reported by others (15, 16) . Clear explanations for the different results obtained in our study and those of others are not readily apparent, although technical considerations such as placental sampling, mode of delivery (15) , as well as differences in ELISAs and approaches to semiquantitative RT-PCR are possibilities. Of note is that in our study TNF␣ message was detectable in all normal term placentas, whereas in other studies TNF␣ mRNA was negligible (15, 16) . Furthermore, other studies have shown the normal placenta to be a source of TNF␣ (6, 17) . Finally, in a study by Opsjon and colleagues of amniotic fluid cytokine levels, it was mentioned (data not shown) that there were no differences in protein levels of FIG. 6 . Cytokine production by villous explants prepared from normal term and preeclamptic placentas. Villous explants were maintained for 24 h under standard tissue culture conditions (21% oxygen; Ⅺ; n ϭ 5) or hypoxia (2% oxygen; f; n ϭ 5). The cytokines evaluated were TNF␣ (A), IL-1␤ (B), IL-1␣ (C), and IL-6 (D). Cytokine concentrations in the conditioned medium were corrected for wet weight of the villous tissue and are expressed as the mean Ϯ SEM. *, Statistical difference between 21% and 2% oxygen; †, significant difference between incubations of normal term and preeclamptic villous explants (P Ͻ 0.05). Values are the mean Ϯ SEM. There was a significant overall difference in TNF␣ concentration between preeclamptic and normal term women (P Ͻ 0.01).
